A retrospective study of risk factors for poor outcomes in methicillin-resistant staphylococcus aureus (MRSA) infection in surgical patients

Journal of Orthopaedic Surgery and Research

Volumn 6, Issue 1, 2011, Pages

  Eseonu, Kelechi C ^a   Middleton, Scott D ^a   Eseonu, Chinyere C ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

AGED; AMPUTATION; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; ORTHOPEDIC SURGERY; OSTEOMYELITIS; POSTOPERATIVE COMPLICATION; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TREATMENT OUTCOME; UNITED KINGDOM;

AGED; AMPUTATION; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ORTHOPEDIC PROCEDURES; OSTEOMYELITIS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 79956193994     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/1749-799X-6-25     Document Type: Article

References (19)

1. Guyot A, Layer G. MRSA - 'bug-bear' of a surgical practice: reducing the incidence of MRSA surgical site infections. Annals of the Royal College of Surgeons of England 2006, 88(2):222-3. 10.1308/003588406X94841, 1964055, 16551425.
2. Gray JW, George RH. Is the incidence of MRSA bacteraemia representative of the rate of MRSA infection in general?. Journal of Hospital Infection 2001, 49(1):79. 10.1053/jhin.2001.1041, 11516192.
3. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire. Cohort Study. British Medical Journal 1997, 333(7562):281.
4. Gould IM. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. International Journal of Antimicrobial Agents 2006, 28(5):379-84. 10.1016/j.ijantimicag.2006.09.001, 17045462.
5. Menon KV, Whiteley MS, Burden P, Galland RB. Surgical patients with methicillin resistant staphylococcus aureus infection: an analysis of outcome using P-POSSUM. JR Coll Surg Edinb 1999, 44:161-3.
6. Hughes CM, Smith MB, Tunney MM. Infection control strategies for preventing the transmission of methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes for older people. Cochrane Database Syst Rev 2008, (1):CD006354.
7. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 2003, 9(12):1179-86. 10.1111/j.1469-0691.2003.00698.x, 14686982.
8. Revised guidelines for the control of Methicillin-resistant Staphylococcus aureus in hospitals. J Hosp Infect 2006, 39(4). British Society for anti-microbial Chemotherapy, hospital Infection society and the Infection Control Nurses Association.
9. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges. Infection Control and Hospital Epidemiology 26:166-174.
10. Rahij A, Rajesh B, Manoj V, et al. Preoperative methicillin-resistant Staphylococcus aureus (MRSA) screening: An effective method to control MRSA infections on elective orthopaedics wards. Surgical Practice 2006, 10(4):135-137.
11. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. Journal of Hospital Infection 1995, 31(1):13-24. 10.1016/0195-6701(95)90079-9, 7499817.
12. Holden MTG, Feil EJ, Lindsay JA, et al. "Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance". Proc Natl Acad Sci USA 2004, 101:9786-91. 10.1073/pnas.0402521101, 470752, 15213324.
13. Johnson AP, Aucken HM, Cavendish S, et al. "Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)". J Antimicrob Chemother 2001, 48(1):143-4. 10.1093/jac/48.1.143, 11418528.
14. Dissemond J. Practical consequences after MRSA identification in chronic wounds. Hautarzt 2007, 58(11):952-8. 10.1007/s00105-007-1403-0, 17926013.
15. Hazzan R, Paul M, Shaked H, et al. Effect of Adequate empiric Antibiotic therapy on the survival of patients with MRSA. Journal of Thrombosis and Haemostasis 2007, 5(1).
16. Alex S, Francesc M, Martinez JA, et al. "Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia". Clinical Infectious Diseases 2008, 46:193-200. 2007, 10.1086/524667, 18171250.
17. Bootsma MC, Diekmann O, Bonten MJ. Controlling Methicillin-resistant Staphylococcus Aureus: Quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 2006, 103:5620-5. 10.1073/pnas.0510077103, 1459403, 16565219.
18. Venditti M, Falcone M, Micozzi A, et al. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case control study. Haematologica 88(8):923-30.
19. Subbe CP, Rao GG, Sedgwick P, Van Heerden N, Groba CB. MRSA: predictor of outcome in critically ill patients. British Journal of Anaesthesia 2000, 84(1):662-662. Number 5.